Literature DB >> 6403495

Reflex control of breathing following inhalation of cigarette smoke in conscious dogs.

L Y Lee, R F Morton, A H Hord, D T Frazier.   

Abstract

The acute ventilatory response to spontaneously inhaled cigarette smoke (750 ml, 10% concentration) was studied in 92 experiments on 6 awake resting dogs. Upon the first or second breath of smoke inhalation, either an apnea or an augmented breath was elicited consistently in each dog, and a hyperpnea occurred subsequently. Minute ventilation (VE) increased from a base line of 3.2 to a peak of 23.9 l/min at 8.3 s (mean values) after the smoke was completely inhaled and returned toward base line in 1-3 min. Cold blocking of both vagi (exteriorized in skin loops) eliminated the initial change in breathing pattern but did not significantly reduce the delayed hyperpnea. Denervation of carotid body chemoreceptors alone abolished 71.5% of the increase in VE induced by cigarette smoke. These results suggest that the apnea or augmented breath immediately following the smoke inhalation is mediated through vagal afferents, whereas the delayed hyperpnea results primarily from the stimulation of carotid body chemoreceptors, presumably by the absorbed nicotine.

Entities:  

Mesh:

Substances:

Year:  1983        PMID: 6403495     DOI: 10.1152/jappl.1983.54.2.562

Source DB:  PubMed          Journal:  J Appl Physiol Respir Environ Exerc Physiol        ISSN: 0161-7567


  3 in total

1.  Bronchoconstriction and apnea induced by cigarette smoke: nicotine dose dependence.

Authors:  E R Beck; R F Taylor; L Y Lee; D T Frazier
Journal:  Lung       Date:  1986       Impact factor: 2.584

2.  A comparison of breathing pattern between transient and steady state hypoxia in awake dogs.

Authors:  L Y Lee; R F Morton
Journal:  Lung       Date:  1984       Impact factor: 2.584

Review 3.  Modulation of airway sensitivity to inhaled irritants: role of inflammatory mediators.

Authors:  L Y Lee; J G Widdicombe
Journal:  Environ Health Perspect       Date:  2001-08       Impact factor: 9.031

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.